ImClone Investigational Site — Flemington, New Jersey

ImClone Investigational Site is a clinical research site located in Flemington, New Jersey, United States 08822.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

ImClone Investigational Site has participated in 1 clinical trials.

Therapeutic areas: Metastatic Renal Cell Carcinoma.

Sponsors: Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for ImClone Investigational Site?

ImClone Investigational Site has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has ImClone Investigational Site conducted?

ImClone Investigational Site has 1 clinical trials on record. Their work covers Metastatic Renal Cell Carcinoma.

Is ImClone Investigational Site accredited by Crixeo Health?

ImClone Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about ImClone Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.